Midodrine as Novel Treatment of Post-Cardiopulmonary Bypass Vasoplegic Syndrome

PHASE4TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 29, 2016

Primary Completion Date

August 8, 2018

Study Completion Date

August 8, 2018

Conditions
Use of Midodrine in Post-cardiopulmonary Bypass Vasoplegic Syndrome
Interventions
DRUG

Midodrine

Oral vasoactive that is metabolized by the liver an peripheral tissues into desglymidodrine, an active metabolite. It produces arteriolar and venous constriction with a subsequent elevation in blood pressure.

DRUG

Methylcellulose

Placebo will consist of inert methylcellulose

All Listed Sponsors
lead

Medstar Health Research Institute

OTHER